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Spinal cord ischemia after elective stent-graft
repair of the thoracic aorta
Roberto Chiesa, MD, Germano Melissano, MD, Massimiliano M. Marrocco-Trischitta, MD,
Efrem Civilini, MD, and Francesco Setacci, MD, Milan, Italy
Objectives: Neurologic deficit after endovascular treatment of the thoracic aorta is a complication reported with variable
frequency that may be associated with severe morbidity and mortality. The mechanism of spinal cord ischemia appears to
be multifactorial and remains ill-defined. We reviewed our experience to investigate the determinants of paraplegia after
stent-graft repair of the thoracic aorta, identify patients at risk, and assess the effectiveness of ancillary techniques.
Methods:Over a 5-year period (June 1999 to December 2004), 103 patients underwent elective endovascular repair of the
thoracic aorta at a university referral center. Indications for treatment were atherosclerotic aneurysms in 88 patients,
chronic type B dissection in 10 patients, and penetrating aortic ulcer in 5 patients. Four of the 103 patients affected with
thoracoabdominal aortic aneurysms had hybrid procedures and were excluded from the cumulative analysis. Twelve
patients with zone 0 and zone 1 aortic arch aneurysms were operated on with synchronous or staged surgical aortic
debranching. Preoperative cerebrospinal fluid (CSF) drainage was instituted in seven selected patients. Neurologic
deficits were assessed by an independent neurologist and classified as immediate or delayed. Patient demographics and
perioperative factors related to the endovascular procedure were evaluated by using univariate statistical analyses.
Results: A primary technical success was achieved in 94 patients (94.9%). At a mean follow-up of 34  14 months, a
midterm clinical success was obtained in 90 patients (90.9%). Four patients (4.04%) had delayed neurologic deficit that
completely resolved after the institution of CSF drainage, steroids administration, and arterial pressure pharmacologic
adjustment. None of the four patients who underwent hybrid procedures for thoracoabdominal aortic aneurysms had
paraplegia or paraparesis. Univariate analyses identified only a perioperative lowest mean arterial pressure (MAP) of<70
mm Hg as a significant risk factor (P < .0001).
Conclusion: Perioperative hypotension (MAP <70 mm Hg) was found to be a significant predictor of spinal cord
ischemia; hence, careful monitoring and prompt correction of arterial pressure may prevent the development of
paraplegia. When the latter occurred, reduction of the CSF pressure by drainage was useful. Patients with a previous or
synchronous abdominal aortic repair may also benefit from CSF drainage as a perioperative adjunct. ( J Vasc Surg 2005;
42:11-7.)Endovascular treatment of thoracic aortic pathologies
is emerging as a less invasive alternative to open surgical
graft replacement. Recent series have reported encouraging
results in terms of technical success and midterm outcomes
compared with traditional open repair.1-3 On the other
hand, the use of thoracic stent grafts has introduced a new
pattern of complications related to their delivery and de-
ployment, as well as to the grafts themselves.
Endoluminal repair allows the avoidance of aortic cross
clamping and its sequelae4; however, the intercostal arteries
covered by the stent graft cannot be reimplanted. The
reported incidence of both immediate and delayed paraple-
gia in patients undergoing endovascular procedures can be
as high as 12% of cases1-8 compared with 2% to 21% after
open repair.9-15 The mechanism underlying the occurrence
of spinal cord ischemia (SCI) after thoracic endovascular
aortic repair (EVAR) has yet to be completely understood
and represents a key issue for further developments of
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doi:10.1016/j.jvs.2005.04.016thoracic stent grafts, because paraplegia results not only in
severe physical disability but is also associated with de-
creased survival rates.16
In this study, we analyzed our most recent 5-year
experience with repairs of thoracic aortic pathologies to
evaluate the incidence and investigate the determinants of
spinal cord ischemia in endovascular procedures, identify
patients at risk, and assess the role and efficacy of prophy-
lactic adjuncts and therapeutic measures.
METHODS
This study was designed as a single-center experience.
We conducted an analysis of data prospectively collected on
a computerized database of all patients undergoing elective
thoracic EVAR at our center. Over a 5-year period (June
1999 to December 2004), 103 patients underwent tho-
racic EVAR. There were 86 men and 17 women with a
mean age of 70.1  7.7 years. Four of the 103 patients
underwent hybrid procedures for thoracoabdominal aortic
aneurysms (TAAs). Because of the presence of possible
confounding factors related to the different nature of the
disease and to the complexity of each of these tailored
surgical and endovascular procedures, these cases were
excluded from the cumulative analysis.
Indications for thoracic EVAR included atherosclerotic
aneurysms in 84 patients, chronic type B dissections in 10,
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endograft deployment is shown in the Fig according to the
“aortic arch map” proposed by Ishimaru.2 Patients catego-
rized as zone 0 and zone 1 received a synchronous or staged
open surgical procedure for aortic debranching, as previously
described.17 In patients with zone 2 aneurysms, a revascular-
ization of the left subclavian artery was performed prophy-
lactically in the first three patients17 and then only selec-
tively in one patient with previous coronary artery bypass
grafting (CABG) that consisted of a left internal thoracic
artery-to-left anterior descending coronary artery. Four
patients underwent thoracic aorta stent-graft repair and
synchronous open abdominal aortic aneurysm (AAA) re-
pair.
The feasibility of the endoluminal intervention and sizing
of stent grafts was determined with preoperative computed
tomography (CT) scans and aortography. The endografts
implanted were Gore Excluder TAG (WL Gore and Assoc,
Flagstaff, Ariz) in 38 cases (28 old devices and 10 new de-
vices), Talent (AVE/Medtronic Inc, Santa Rosa, Calif) in 4
cases, Endofit (Endomed Inc, Phoenix, Ariz) in 11 cases, and
Zenith TX1 (46 cases) and TX2 (4 cases) devices (William
Cook Europe Aps, Bjaeverskov, Denmark).
Patients were operated on under spinal anesthesia (47
cases), local anesthesia (6 cases), or general anesthesia (50
cases). Preoperative cerebral spinal fluid (CSF) drainage
was instituted in seven selected patients. Based on data
previously reported in the literature and our experience in
open surgical repair of TAA, we used CSF drainage in
patients with an aneurysm involving critical intercostal ar-
teries (T8 to L2), in those requiring the coverage of a long
descending thoracic aortic segment (20 cm), and in pa-
tients with a previous AAA repair. Intraoperative trans-
esophageal echocardiography monitoring was used for aor-
tic dissection.
All the procedures were performed in the operating
room, and a portable digital C-arm image intensifier with
subtraction angiography and roadmap capabilities was
used. No temporary or permanent prosthetic conduits were
used to access the arterial system. The preferred entry sites
were the common femoral arteries. Access was also through
the common iliac artery in three cases, through the left
branch of a previous aortobiiliac graft in one case, and
through the abdominal graft in the four patients who had
synchronous AAA surgical repair.
Neurologic deficits were defined as paraplegia or para-
paresis according to the Tarlov scale18 (Table I) and as-
sessed by an independent neurologist. Paraplegia or para-
paresis observed immediately or upon awakening were
defined as immediate neurologic deficits. Those occurring
after a period of normal neurologic function were classified
as delayed deficits.
We investigated the influence of the following demo-
graphic factors as possible predictors of postoperative SCI:
age, gender, cardiac risk factor (previously documented
myocardial infarction, ongoing angina pectoris, previous
coronary bypass surgery, percutaneous transluminal coro-
nary angioplasty, or a combination), diabetes mellitus (hy-perglycemia requiring diet, oral medication, or insulin
treatment), hypertension (medication for hypertension or
arterial pressure 160/95 mm Hg), cerebrovascular dis-
ease (history of stroke or transient ischemic attacks), pul-
Anatomic location of proximal landing zone of thoracic stent graft
in 103 patients according to the aortic map.
Table I. Modified Tarlov scoring scale
Scale Motor function Deficit
0 No lower extremity movement Paraplegia
1 Lower extremity motion without gravity Paraplegia
2 Lower extremity motion against gravity Paraplegia
3 Able to stand with assistance Paraparesis
4 Able to walk with assistance Paraparesis
5 Normal Normalmonary disease (chronic obstructive pulmonary disease or
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smoking (current smoker), and surgical AAA repair.
The following perioperative factors related to the en-
dovascular procedure were also analyzed: indication for
EVAR (aneurysm, chronic dissection, penetrating aortic
ulcers), anatomic location of proximal landing zone (0 to
4), length of devices, intraoperative device migration, aor-
tic occlusion during graft deployment (including balloon-
ing), type I or type II endoleak at intraoperative control,
deliberate covering of the left subclavian artery by the stent
graft, and intraoperative and postoperative (48 hours
after the procedure) lowest mean arterial pressure (MAP)
70 mmHg. A systematic assessment of stent-graft occlu-
sion of the intercostal or lumbar arteries between T8 and
L2 was not performed because of difficulties related to
significant aortic tortuosity and intraluminal thrombosis.
Univariate analyses were conducted for patient demo-
graphics and considered perioperative risk factors as shown
i n Tables II and III. Student’s t test and the 2 test or Fisher’s
exact test were performed as appropriate. All analyseswere run
on the Statistical Package for the Social Sciences (SPSS) PC
version 9.0 software (SPSS Inc, Chicago, Ill).
RESULTS
According to the reporting standards for endovascular
aortic aneurysm repair,19 a primary technical success was
achieved in 94 (94.9 %) of the 99 subjects included in the
cumulative analysis. One patient died intraoperatively be-
cause of graft migration,20 and four patients had a residual
type Ia endoleak that was left untreated because the aortic
proximal neck was deemed inadequate for further endovas-
cular procedures. A type II endoleak was also observed in
eight patients.
Stroke occurred in one patient who had endovascular
repair of a zone 3 penetrating aortic ulcer and in two
patients treated for a zone 0 aortic aneurysm by means of
synchronous surgical aortic debranching and stent-graft
repair of the aortic arch with intentional coverage of the
supra-aortic vessels. No positive conclusions can be drawn
regarding the cause of this complication being related to
possible ischemic or embolic events that were secondary to
surgical and endovascular procedures. Postoperative com-
plications also included acute renal failure reversed without
dialysis in two patients, acute respiratory failure in one, and
seizure in one patient.
An initial (30-day) clinical success19 was obtained in 91
patients (91.9%). We recorded two postoperative in-hospital
deaths caused by stroke in one patient and acute respiratory
failure in the other. One patient electively underwent a
successful surgical conversion 2 weeks after the procedure
because of a total collapse of the graft.20
A short-term clinical success19 was achieved in 91 pa-
tients (91.9%). Two patients who suffered a perioperative
stroke died, and the complete spontaneous resolution of a
Type Ia endoleak was observed in two patients.
At amean follow-up of 34 14months, including only
1-month survivors, midterm clinical success19 was obtained
in 90 patients (90.9%), including eight with type II en-doleak in the absence of aneurysm expansion. One type Ia
endoleak resolved completely without any further interven-
tion. One patient underwent a successful surgical conver-
sion 43 months after EVAR because of a late fracture of the
longitudinal support wire of a Gore Excluder TAG endo-
prosthesis. Aneurysm expansion was observed in one pa-
tient. Five patients died of unrelated causes. One patient
was lost to follow-up.
Spinal cord ischemia. Four patients (4.04%) had de-
layed neurologic deficit. The first, a 70-year-old man who
previously had a surgical AAA repair, underwent endovas-
cular exclusion of an aneurysm of the descending thoracic
aorta (zone 4) with a Zenith TX1 42-  139-mm device.
The procedure was performed under spinal anesthesia. No
intraoperative complications occurred. His postoperative
course was characterized by wide fluctuations inMAP, with
a lowest value of 70 mm Hg. A left lower extremity
neurologic deficit (Tarlov score, 2) developed 48 hours
after EVAR. It completely resolved within 72 hours after
pharmacologic adjustment to keep MAP 90 mm Hg,
intravenous steroids administration (dexamethasone, 24
mg/day), and institution of CSF drainage. Cerebrospinal
fluid was allowed to freely drain with gravity when intrathe-
cal pressure was 10 mm Hg. The highest registered CSF
pressure was 15 mmHg, and a total of 280 mL of CSF was
drained. A CT scan disclosed no signs of spinal cord infarc-
tion. The remainder of his postoperative course was un-
eventful, and the patient was discharged on postoperative
day 7.
In the second case, a 68-year-old-man underwent en-
dovascular repair of a zone 4 thoracic aortic aneurysm
under general anesthesia. A Gore Excluder TAG 30- 
150-mm endograft was successfully deployed without any
technical complications. Upon awakening, the patient
showed no neurologic deficits. During his immediate post-
operative course, the patient had significant blood pressure
instability, and 24 hours after the procedure, paraplegia (Tar-
lov score, 1) developed after a hypotensive episode (MAP
value was 60mmHg). The neurologic deficit was completely
reversed 12 hours by means of maintenance of MAP of
90 mm Hg, CSF drainage (highest CSF pressure, 16 mm
Hg; total CSF drained, 190mL), and steroids administration.
The patient was discharged on postoperative day 5.
The third patient was a 70-year-old man who previ-
ously had a left internal thoracic artery-left anterior de-
scending coronary artery CABG. He underwent synchro-
nous left carotid-subclavian bypass and endovascular
exclusion of a zone 2 aortic arch aneurysm with a Cook
Zenith TX1 (36 156 mm) under general anesthesia. The
procedure was uneventful. The early postoperative period
was characterized by hemodynamic instability, with the
lowest MAP 70 mm Hg. On postoperative day 4, para-
paresis developed (Tarlov score, 4) associated with ataxia.
The neurologic deficit completely resolved72 hours after
institution of the treatment described previously, including
drainage of 230mL of CSF (highest CSF pressure value, 14
mm Hg). The patient was discharged well 7 days after the
procedure.
JOURNAL OF VASCULAR SURGERY
July 200514 Chiesa et alThe last patient was an 80-year-old man with synchro-
nous abdominal aortic and zone 3 thoracic aortic aneu-
rysms. He underwent an abdominal aortic surgical repair
with 16-mm Dacron (DuPont, Wilmington, Del) graft
interposition followed by the insertion through the abdom-
inal graft, by means of a pursestring suture, of a Zenith
Cook TX1 40-  200-mm endograft that was successfully
deployed distal to the subclavian artery. The patient recov-
ered from general anesthesia without neurologic deficit.
On postoperative day 1, he experienced persistent hypoten-
sion for about 30 minutes, with lowest levels of MAP of
60 mm Hg, and lower left hemiparesis (Tarlov score, 4)
developed. The patient began to recover as the hypotension
was pharmacologically reversed, and the deficit completely
regressed 24 hours after the institution of CSF drainage
(highest CSF pressure, 15 mmHg; total CSF drained, 200
mL) and steroids administration.
Spinal cord evaluation through magnetic resonance
Table II. Univariate analysis of the association between p
Variables No paraplegia n (%
Age (mean  SD) 70.0  7.8
Gender (M/F) 78 (82.1)/17 (17.
Cardiac risk factor 46 (48.4)
Diabetes mellitus 10 (10.5)
Hypertension 66 (69.5)
Cerebrovascular disease 11 (11.6)
Pulmonary disease 47 (49.5)
Renal failure 13 (13.7)
Smoking 63 (66.3)
Indication to EVAR
Aneurysm 80 (84.2)
Chronic dissection 10 (10.5)
PAU 5 (5.3)
AAA surgical repair 11 (11.6)
M, Male; F, female; EVAR, endovascular aortic repair; PAU, penetrating ao
*2 statistics or Fisher’s exact test.
†Student’s t test.
Table III. Univariate analysis of the association between p
Variables No para
Proximal landing zone
0
1
2 20
3 34
4 29
Length of device (mean  SD) 149.
Intraoperative device migration
Aortic occlusion during graft deployment 14
Type I endoleak‡
Type II endoleak‡
Left subclavian artery occlusion 29
Lowest MAP 70 mm Hg
MAP, Mean arterial pressure.
*2 statistics or Fisher’s exact test.
†Student’s t test.
‡Intraoperative control.imaging (MRI) was not performed in any of these patients.In three patients, a Cook device had been implanted and
MRI was contraindicated by the manufacturer because of
the presence of steel components.
None of the four patients who had hybrid procedures
for TAA had neurologic deficits. The analysis of the impact
of patient characteristics and perioperative variables are
summarized in Tables II and III. None of the patient
demographics was found to be a predictor of paraplegia;
however, patients with previous (9 cases) or synchronous (4
cases) AAA repair had a trend of an increased risk of
neurologic deficit (P  .08). Univariate analysis identified
only a perioperative lowest MAP of 70 mm Hg as a
significant risk factor (P  .0001).
DISCUSSION
Postoperative neurologic deficit is a dreaded and dev-
astating possible complication of thoracic and thoracoab-
dominal aortic repair. The risk of SCI also remains signifi-
t demographics and paraplegia
Paraplegia n (%) P*
72.0  5.6 .62†
4 (100)/0 (0) 1.0
1 (25.0) .61
0 (0) 1.0
4 (100) .31
0 (0) 1.0
3 (75.0) .61
1 (25.0) .46
3 (75.0) 1.0
.68
4 (100) —
0 (0) —
0 (0) —
2 (50.0) .08
lcers; AAA, abdominal aortic aneurysm.
perative risk factors and paraplegia
a n (%) Paraplegia n (%) P*
.89
3) 0 (0) —
3) 0 (0) —
0) 1 (25.0) —
8) 1 (25.0) —
5) 2 (50.0)
8.4 162.7  26.1 .49†
3) 0 (0) 1.0
7) 1 (25.0) .48
2) 0 (0) 1.0
4) 1 (25.0) .29
5) 0 (0) 1.0
2) 4 (100) .0001atien
)
2)
rtic uerio
plegi
6 (6.
6 (6.
(21.
(35.
(30.
3  3
5 (5.
(14.
4 (4.
7 (7.
(30.
4 (4.cant after endovascular procedures and appears to be
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anisms.
Spinal cord perfusion pressure depends on changes of the
gradient between arterial pressure and CSF pressure. Aortic
cross clamping performed during open repair of thoracic
aortic pathologies causes a decrease in distal arterial pressure
that may alter spinal cord blood perfusion. To reduce the risk
of neurologic complications, a number of ancillary techniques
have been developed and used (Table IV).21-30 No method
has been ultimately successful in the prevention of paraplegia,
however.
Endovascular repair does not require aortic cross
clamping and therefore generally reduces hemodynamic-
related derangements. This may not be always the case,
however, because errant stent-graft deployment can result
in a period of aortic occlusion that leads to paraplegia.31
Moreover, restoration of aortic patency after camp release
or completion of device deployment may prime a spinal
cord reperfusion injury whose magnitude is related to the
severity and duration of the ischemic insult. As a prophy-
lactic measure during EVAR, CSF drainage is most com-
monly used only in selected patients, including those with
synchronous or previous abdominal aortic repair.32 As a
treatment for postoperative paraplegia of delayed onset,
CSF drainage often appeared to be useful33-35 although
not always effective.32
Another important issue is the great variability of the
spinal cord blood supply. The significant role of the inter-
costal arteries between T8 and L2 is supported by the direct
correlation between the risk of adverse neurologic events
and TAA extent. Furthermore, the reimplantation of criti-
cal intercostal arteries has been shown to significantly lower
the risk of late neurologic deficit11 even though a low
incidence of paraplegia (2%) was also reported in a series
with no intercostal arteries reattachment.15
Overall, it appears that rather than being dependent on
single segmental arteries, namely the artery of Adamkiewicz,
spinal cord perfusion highly depends on a collateral circula-
tion36 that is extremely vulnerable to abrupt hemodynamic
changes. In this respect, postoperative hypotension appears to
be a major determinant of delayed-onset SCI.37
Thoracic endografts overlie and exclude the intercostal
arteries originating from the aneurysm and the proximal
and distal landing zones; thus, the coverage of a long
thoracic aortic segment has been reported to be a signifi-
cant risk factor for SCI.32 Patients who have open AAA
repair also appear to be prone to such a risk because of the
marginal spinal cord collateral blood supply secondary to
the ligation of lumbar arteries performed during the surgi-
cal procedure.32,38 Also, proximal collateral circulation of
the spinal cordmay be put at risk by the occlusion of the left
subclavian artery (landing zone 2) that abolishes the con-
tribution to the blood supply provided by the anterior
spinal artery, a branch of the ipsilateral vertebral artery.
Finally, SCI could be precipitated by the late sealing of a
type II endoleak39 or late thrombosis of collateral path-
ways.To predict the risk of postoperative neurologic compli-
cations after thoracic EVAR, Kieffer et al40 propose a
preoperative angiographic assessment of intercostal arter-
ies; however, this procedure appears to be cumbersome and
carries the risk of embolization. The use of somatosensory
evoked potential has also been advocated to achieve this
goal.28 The reported strategies include somatosensory
evoked potential monitoring during a 20-minute deploy-
ment of a retrievable stent graft41 or during a 15-minute
segmental balloon occlusion of the aorta, with or without
an external axillofemoral bypass.42 The occurrence of isch-
emic changes during these tests may jeopardize the com-
pletion of the procedure, however, and the risk of emboli-
zation remains considerable.32
Our data showed that none of the considered preoper-
ative risk factors were a determinant of paraplegia. These
results have relevant clinical implications, because endovas-
cular treatment has been most commonly indicated in poor
surgical candidates whose severe comorbidities have the
potential to influence neurologic outcome. The lack of
collateral spinal cord blood supply through the lumbar
arteries appears to be a relevant risk factor even though it
did not reach statistical significance in our series. The
intentional occlusion of the left subclavian was not a pre-
dictor of paraplegia and neither was the exclusion of an
extensive thoracic aortic segment.
Among the perioperative variables, only a lowest MAP
of 70 mm Hg was a significant determinant of delayed
neurologic deficit. This finding is consistent with previous
reports regarding thoracic and thoracoabdominal aortic
open repair.9,37
The small number of events in our series limited the
power of the statistical analyses. However, even as a merely
descriptive report, our experience addresses the importance
of hemodynamic control to prevent postoperative neuro-
logic deficits and encourages aggressive, postoperative care
of these patients. In our practice, we now try to maintain a
perioperative MAP of 90 mm Hg9 and use CSF drainage
in patients deemed at high risk, including those who re-
ceived AAA repair. In this respect, patients with synchro-
nous thoracic and AAA, which we earlier treated simulta-
neously for both pathologies, currently undergo staged
procedures to better allow the development of collaterals
Table IV. Ancillary techniques for prevention of spinal
cord ischemia during thoracic aortic repair
Distal aortic perfusion21
Hypothermic circulatory arrest22
Local hypothermia23
Pharmacologic agents
●steroids24
●naloxone hydrochloride25
●barbiturates26
●papaverine hydrochloride27
Spinal cord monitoring28
“Clamp-and-sew” technique29
Cerebrospinal fluid drainage30for spinal cord blood supply. In the case of delayed para-
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also used to keep the CSF pressure 10 mm Hg and
possibly reverse the deficit. Such drainage is maintained for
72 hours after open repair, as previously suggested.30
Our results show that elective thoracic aortic stent-graft
repairs have a favorable impact on postoperative neurologic
outcome, particularly with regards to severity of SCI. On-
going technical developments of endovascular procedures,
such as customized fenestrated grafts that incorporate in-
tercostal arteries, may further reduce the risk of paraplegia
that represents one of the ultimate benchmarks for thoracic
EVAR as an alternative to traditional open repair.
We thank Dr Giliola Calori, Statistical Unit, Scientific
Institute San Raffaele, for her help in statistical analysis of
the data of the manuscript.
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